Whilst our investigation of the impact of a novel variant predicted to result in a loss of PAX4 function (p.Tyr186X) demonstrated that PAX4 haploinsufficiency is insufficient to cause monogenic diabetes, it was consistent with a negative impact on beta cell function. The gene discussed is PAX4; the disease is diabetes mellitus.